FSRAX
Price
$9.29
Change
+$0.03 (+0.32%)
Updated
Jul 13 closing price
Net Assets
517.11M
HBLCX
Price
$14.61
Change
-$0.02 (-0.14%)
Updated
Jul 13 closing price
Net Assets
11.12B
Interact to see
Advertisement

FSRAX vs HBLCX

FSRAX vs HBLCX Comparison Chart in %
View a ticker or compare two or three
VS
FSRAX vs. HBLCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSRAX is a StrongBuy and HBLCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLCX has more cash in the bank: 11.1B vs. FSRAX (517M). FSRAX pays higher dividends than HBLCX: FSRAX (4.02) vs HBLCX (2.47). FSRAX was incepted earlier than HBLCX: FSRAX (21 years) vs HBLCX (20 years). HBLCX (1.65) is less costly to investors than FSRAX (1.04). HBLCX is a more actively managed with annual turnover of: 90.00 vs. FSRAX (29.00). FSRAX has a lower initial minimum investment than HBLCX: FSRAX (0) vs HBLCX (2000). HBLCX IRA initial investment is lower compared to FSRAX: HBLCX (2000) vs FSRAX (500). FSRAX annual gain was more profitable for investors over the last year : 12.14 vs. HBLCX (4.05). FSRAX return over 5 years is better than : 30.55 vs. HBLCX (1.87).
FSRAXHBLCXFSRAX / HBLCX
Total Expense Ratio0.951.6558%
Annual Report Gross Expense Ratio1.041.6563%
Fund Existence21 years20 years-
Gain YTD6.8843.951174%
Front Load4%N/A-
Min. Initial Investment02000-
Min. Initial Investment IRA500200025%
Net Assets517M11.1B5%
Annual Yield % from dividends4.022.47163%
Returns for 1 year12.144.05299%
Returns for 3 years27.0915.85171%
Returns for 5 years30.551.871,637%
Returns for 10 years56.2828.44198%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INFY11.500.56
+5.12%
Infosys Limited
ZJYL1.860.06
+3.33%
Jin Medical International Ltd.
EPR59.810.19
+0.32%
EPR Properties
PLOW43.080.07
+0.16%
Douglas Dynamics
PLX2.39-0.05
-2.05%
Protalix BioTherapeutics